CompletedPhase 1NCT00774358
Interleukin-2 Treatment for Wiskott-Aldrich Syndrome
Studying Wiskott-Aldrich syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Soma Jyonouchi
- Principal Investigator
- Soma Jyonouchi, MD, M.D., Ph.DChildren's Hospital of Philadelphia
- Intervention
- Interleukin-2(drug)
- Enrollment
- 9 enrolled
- Eligibility
- All sexes
- Timeline
- 2008 – 2016
Study locations (3)
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
- The Texas Children's Hospital, Houston, Texas, United States
Collaborators
Baylor College of Medicine
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00774358 on ClinicalTrials.govOther trials for Wiskott-Aldrich syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07534033Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung CancerZhujiang Hospital
- ACTIVE NOT RECRUITINGPHASE3NCT03837483A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich SyndromeFondazione Telethon
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT02333760Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich SyndromeGenethon